Sian Bigora serves as Executive at Processa Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Sian Bigora has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 1, 2026 involved exercising options for 249 shares valued at $0.
Sian Bigora currently holds 1,604 shares of Processa Pharmaceuticals, Inc. (PCSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sian Bigora has been a net neutral trader of PCSA stock. They have purchased $0 and sold $0 worth of shares.
Sian Bigora's most recent insider trade was on Jan 1, 2026, when they sold 249 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 10, 2024 | PCSA | $0 | Option Exercise | 644 | $N/A | Discretionary |
| Jul 10, 2024 | PCSA | $385 | Payment | 225 | $1.71 | Discretionary |
| Apr 5, 2024 | PCSA | $1.0K | Payment | 368 | $2.79 | Discretionary |
| Apr 5, 2024 | PCSA | $0 | Option Exercise | 1,675 | $N/A | Discretionary |
| Jan 1, 2024 | PCSA | $1.0K | Payment | 368 | $2.79 | Discretionary |
| Jan 1, 2024 | PCSA | $0 | Option Exercise | 1,675 | $N/A | Discretionary |
| Aug 5, 2022 | PCSA | $0 | Option Exercise | 7,601 | $N/A | Discretionary |
| Aug 5, 2021 | PCSA | $0 | Award | 7,601 | $N/A | Discretionary |